和铂医药-B11月4日斥资258.49万港元回购20万股
HBM HOLDINGSHBM HOLDINGS(HK:02142) Zhi Tong Cai Jing·2025-11-04 12:08

Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will repurchase 200,000 shares [1] - The total expenditure for the buyback is HKD 2.5849 million [1] - The buyback is scheduled for November 4, 2025 [1]